Alzheimer’s Disease (AD) is a significant health concern worldwide with enormous social and economic impact globally. The gradual deterioration of cognitive functions and irreversible neuronal losses are primary etiological features of the disease. Even after decades of research, most therapeutic options are merely symptomatic, and drugs in clinical practice present numerous side effects. Lack of effective diagnostic techniques prevents the early prognosis of disease, resulting in a gradual deterioration in the quality of life. Furthermore, the mechanism of cognitive impairment and AD pathophysiology is poorly understood. Microfluidics exploits different microscale properties of fluids to mimic environments on microfluidic chip-like devices. These miniature multichambered devices can be used to grow cells and 3D tissues in vitro, analyze cell-to-cell communication, decipher the roles of neural cells like microglia, and gain insights into AD pathophysiology. This review focuses on the applications and impact of microfluidics on AD research. We discuss the technical challenges and possible solutions provided by this new cutting-edge technique to understand disease-associated pathways and mechanisms.

Tin (IV) oxide nanoparticles (SnO2 NPs) have received a lot of interest because of their interesting features. SnO2 NPs have proven productive in a range of fields, including water purification, supercapacitors, batteries, antibacterial and antioxidant agents, and others. SnO2-based nanoparticles found a wide range of applications after incorporating materials with varying chemical compositions. SnO2 NPs and their nanocomposites have been used effectively as antibacterial agents against various pathogenic bacteria, photocatalysts for dye degradation, and electrode materials for supercapacitors (SCs). This article covers the characteristics of SnO2 NPs, SnO2 nanocomposite materials, applications of SnO2 NPs and their composite materials, including antibacterial, energy storage, and photocatalysis, as well as some significant recent studies.